Alternatives to Emedgene

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

AI-powered platform for cancer diagnostics in digital pathology.

AI-powered IVF clinic solutions for digitization and automation.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered workflow automation for pharmacy and healthcare operations.

Self-service data analytics platform for healthcare ecosystems, enabling exploration and discovery.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered spatial biology platform for precision medicine and drug development.

AI platform automating healthcare phone calls to improve patient access and care coordination.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Digital at-home sleep lab solution for increased clinic efficiency and patient care.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

AI-powered video health data platform for remote vital sign monitoring via smartphone.

Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.

AI-powered medical imaging solutions for sharper images, faster scans, and improved efficiency.

Harnessing genetic data for digital insights in rare and germline disorders.

Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

AI-powered surgical intelligence platform for improving surgical quality and outcomes.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

AI-powered diagnostic system for predictive analytics in healthcare.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Cloud platform for secure sharing and analysis of real-world health data for life sciences.

AI-powered vocal biomarkers for health screening, detection, monitoring, and prediction.

Develops toilet-integrated diagnostic technology for early health condition detection.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Developing a digital pill to rebalance brain networks using imperceptible micro-stimulations.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI-powered real-time guidance and quality assessment for cardiac ultrasound imaging.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

AI-powered system for real-time sperm cell analysis and selection for fertility treatments.

DiA Imaging Analysis provides AI-powered ultrasound software to automate image analysis for clinicians.

AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

MDI Health provides an AI-powered medication management platform to optimize patient care and reduce healthcare costs for providers and payors.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Developing CORA, a smart exam for early detection of coronary artery disease.

AI agents that automate healthcare administrative workflows, improving efficiency and patient care.

AI-powered communication solutions for individuals with severe motor disabilities.

Nevia Bio is a femtech startup focused on early detection of women's health conditions.

Global network of clinics using AI and data science to treat age-related cognitive and functional decline.

AI-powered platform to enhance fertility treatment success rates and patient experience.